Identification of Oral Macrocyclic Peptide Inhibitors Against IL-17 for the Treatment of Psoriasis
Time: 2:30 pm
day: Conference Day One
Details:
- Designing mRNA display libraries with diverse chemical properties and scaffolds
- Combining assay and computational approaches for initial peptide hit identification and selection, with high affinity and specificity for targets
- Further constraining or optimizing peptides to become viable, orally available therapeutics
